Integrated, process-savvy technologies are vital to overcoming the virus-like particles purification bottleneck.

With the continuing COVID-19 pandemic, several researchers have brought out candidate vaccines, some of which have undergone human testing. However, it is unclear whether they are genuinely protective ...

Advantages of Utilizing a Light-Scattering Toolbox in Vaccine Development Virus-like particles (VLPs) are biomolecular nanoparticles formed by controlled self-assembly of viral structural proteins.

Nanomedicine. 2014;9(12):1857-1868. Virus-like particles (VLPs) are self assembled protein structures often containing hollow interiors. VLPs can be produced heterologously through different hosts ...

Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren't infectious, they show promise as vaccine platforms for many viral diseases, ...

In a study published in the latest issue of the Scientific Reports, a team of researchers constructed virus-like particles (VLPs) composed of severe acute respiratory syndrome coronavirus 2 ...

Virus-like particles (VLPs), mere shells of actual viruses, can be used to create vaccines in weeks instead of months, according to Novavax Inc. of Rockville, Md. The research could make vaccine ...